us fda to blame for drug approval slow-down?
Post on 09-Dec-2016
212 views
TRANSCRIPT
Inpharma 1646 - 12 Jul 2008
■ The US FDA is responsible for the down-turn innew drug approvals, say research-based drug firms.Marketletter: Pharma News Daily reports that manyanalysts see the agency as having taken a stronger lineon safety in the wake of the withdrawal of Merck andCo’s COX-2 inhibitor rofecoxib [Vioxx], resulting in aslow-down in new approvals. However, the director ofthe FDA’s Center for Drug Evaluation, JanetWoodcock, rejects the analysis, blaming a reduction inapplications for the lowest number of marketingapprovals (19 in 2007) since 1984.FDA slows down approvals, firms claim. Marketletter: Pharma News Daily :[1 page], 2 Jul 2008. Available from: URL: http://www.news.marketletter.com 801035790
1
Inpharma 12 Jul 2008 No. 16461173-8324/10/1646-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved